Goldman Sachs’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,298
| Closed | -$4K | – | 5863 |
|
|
2022
Q2 | $4K | Sell |
12,298
-495,892
| -98% | -$161K | ﹤0.01% | 5621 |
|
|
2022
Q1 | $346K | Sell |
508,190
-285
| -0.1% | -$194 | ﹤0.01% | 4818 |
|
|
2021
Q4 | $1.18M | Buy |
508,475
+466,289
| +1,105% | +$1.08M | ﹤0.01% | 3900 |
|
|
2021
Q3 | $193K | Sell |
42,186
-12,844
| -23% | -$58.8K | ﹤0.01% | 4877 |
|
|
2021
Q2 | $244K | Buy |
55,030
+20,423
| +59% | +$90.6K | ﹤0.01% | 4817 |
|
|
2021
Q1 | $252K | Buy |
34,607
+4,317
| +14% | +$31.4K | ﹤0.01% | 4720 |
|
|
2020
Q4 | $231K | Buy |
30,290
+976
| +3% | +$7.44K | ﹤0.01% | 4204 |
|
|
2020
Q3 | $266K | Sell |
29,314
-10,323
| -26% | -$93.7K | ﹤0.01% | 3956 |
|
|
2020
Q2 | $335K | Buy |
39,637
+13,567
| +52% | +$115K | ﹤0.01% | 3777 |
|
|
2020
Q1 | $129K | Buy |
26,070
+898
| +4% | +$4.44K | ﹤0.01% | 4108 |
|
|
2019
Q4 | $181K | Buy |
25,172
+1,480
| +6% | +$10.6K | ﹤0.01% | 4012 |
|
|
2019
Q3 | $256K | Buy |
+23,692
| New | +$256K | ﹤0.01% | 3835 |
|
|
2019
Q1 | – | Sell |
-64,949
| Closed | -$675K | – | 4285 |
|
|
2018
Q4 | $675K | Buy |
+64,949
| New | +$675K | ﹤0.01% | 3306 |
|